| Patent | Date |
|---|
Triazine Formulations With A Second Active Ingredient And Surfactant(s)
App 20220265665 - LE MEUR; ANNE-CLAIRE ; et al. | 2022-08-25 |
Polymer Packaging And Use Thereof For Preserving A Pharmaceutical Composition
App 20220257809 - Lacoste; Sandrine ; et al. | 2022-08-18 |
Triazine formulations with a second active ingredient and surfactant(s)
Grant 11,331,321 - Le Meur , et al. May 17, 2 | 2022-05-17 |
Solid injectable veterinary implants comprising monocyclic lactone
Grant 11,318,156 - Guimberteau , et al. May 3, 2 | 2022-05-03 |
Triazine Formulations With A Second Active Ingredient And Surfactant(s)
App 20220023304 - LE MEUR; ANNE-CLAIRE ; et al. | 2022-01-27 |
Triazine Formulations With A Second Active Ingredient And Surfactant(s)
App 20220023305 - LE MEUR; ANNE-CLAIRE ; et al. | 2022-01-27 |
Palatable oral veterinary compositions
Grant 11,090,270 - Peyrot , et al. August 17, 2 | 2021-08-17 |
Veterinary Compositions And The Uses Thereof For Controlling Iron Deficiencies In Non-human Mammals
App 20210220319 - Guimberteau; Florence ; et al. | 2021-07-22 |
Palatable oral veterinary compositions
Grant 11,020,350 - Peyrot , et al. June 1, 2 | 2021-06-01 |
Composition For Treating Parasites Infestations
App 20200306220 - GUIMBERTEAU; Florence ; et al. | 2020-10-01 |
Composition Containing Moxidectin For Treating Parasites Infestations
App 20200281848 - GUIMBERTEAU; Florence ; et al. | 2020-09-10 |
Composition For Treating Worms Infestations
App 20200222440 - GUIMBERTEAU; Florence ; et al. | 2020-07-16 |
Palatable Oral Veterinary Compositions
App 20200163891 - Peyrot; Laurence ; et al. | 2020-05-28 |
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
Grant RE47,084 - Castan , et al. October 16, 2 | 2018-10-16 |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
Grant 10,004,693 - Castan , et al. June 26, 2 | 2018-06-26 |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
Grant 9,814,684 - Castan , et al. November 14, 2 | 2017-11-14 |
Parenteral Compositions And Uses Thereof
App 20170304450 - GUIMBERTEAU; Florence ; et al. | 2017-10-26 |
Oral Pharmaceutical Formulation In The Form Of An Aqueous Suspension Of Microcapsules For The Modified Release Of Active Principle(s).
App 20170281558 - Castan; Catherine ; et al. | 2017-10-05 |
Novel Method For The Topical Application Of Veterinary Agents
App 20170136080 - Guimberteau; Florence ; et al. | 2017-05-18 |
Multimicroparticulate pharmaceutical forms foe oral administration
App 20160338966 - Guimberteau; Florence ; et al. | 2016-11-24 |
Oral Pharmaceutical Formulation In The Form Of Aqueous Suspension For Modified Release Of Active Principle(s)
App 20150374636 - Castan; Catherine ; et al. | 2015-12-31 |
Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s)
App 20150374635 - Castan; Catherine ; et al. | 2015-12-31 |
Triazine Formulations With A Second Active Ingredient And Surfactant(s)
App 20150313940 - LE MEUR; ANNE-CLAIRE ; et al. | 2015-11-05 |
Prolonged-release Multimicroparticulate Oral Pharmaceutical Form
App 20150313846 - Guimberteau; Florence ; et al. | 2015-11-05 |
Palatable Oral Veterinary Compositions
App 20150147393 - Peyrot; Laurence ; et al. | 2015-05-28 |
Prolonged-release multimicroparticulate oral pharmaceutical form
Grant 9,023,400 - Guimberteau , et al. May 5, 2 | 2015-05-05 |
Oral dosage form comprising an antimisuse system
Grant 8,895,063 - Guimberteau , et al. November 25, 2 | 2014-11-25 |
Microcapsules with modified release of active principles with low solubility for oral delivery
Grant 8,821,935 - Guimberteau , et al. September 2, 2 | 2014-09-02 |
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
Grant 8,734,850 - Castan , et al. May 27, 2 | 2014-05-27 |
Anti-misuse Microparticulate Oral Pharmaceutical Form
App 20140072644 - Guimberteau; Florence ; et al. | 2014-03-13 |
Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility
Grant 8,652,523 - Guimberteau , et al. February 18, 2 | 2014-02-18 |
Anti-misuse microparticulate oral pharmaceutical form
Grant 8,652,529 - Guimberteau , et al. February 18, 2 | 2014-02-18 |
Anti-misuse microparticulate oral pharmaceutical form
Grant 8,445,023 - Guimberteau , et al. May 21, 2 | 2013-05-21 |
ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS
App 20110159088 - Guimberteau; Florence ; et al. | 2011-06-30 |
Oral Pharmaceutical Formulation In The Form Of An Aqueous Suspension Of Microcapsules For Modified Release Of Amoxicillin
App 20110129539 - Castan; Catherine ; et al. | 2011-06-02 |
Oral Pharmaceutical Formulation In The Form Of Aqueous Suspension For Modified Release Of Active Principle(s)
App 20110117205 - Castan; Catherine ; et al. | 2011-05-19 |
Multimicroparticulate Pharmaceutical Forms For Oral Administration
App 20110104266 - Guimberteau; Florence ; et al. | 2011-05-05 |
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
Grant 7,910,133 - Castan , et al. March 22, 2 | 2011-03-22 |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
Grant 7,906,145 - Castan , et al. March 15, 2 | 2011-03-15 |
Anti-misuse Microparticulate Oral Drug Form
App 20100266701 - Guimberteau; Florence ; et al. | 2010-10-21 |
Anti-misuse Microparticulate Oral Pharmaceutical Form
App 20100092553 - Guimberteau; Florence ; et al. | 2010-04-15 |
Novel acetysalicylic acid formulations
App 20100009005 - Soula; Gerard ; et al. | 2010-01-14 |
Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists
App 20090311315 - Castan; Catherine ; et al. | 2009-12-17 |
Solid oral form provided with a double release profile
App 20090291137 - Guimberteau; Florence ; et al. | 2009-11-26 |
Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same
App 20090220611 - Dargelas; Frederic ; et al. | 2009-09-03 |
Oral Pharmaceutical Form of Losartan
App 20090123536 - Castan; Catherine ; et al. | 2009-05-14 |
Anti-Misuse Microparticulate Oral Drug Form
App 20090041838 - Guimberteau; Florence ; et al. | 2009-02-12 |
Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form
App 20080305160 - Guimberteau; Florence ; et al. | 2008-12-11 |
Solid, Oral, Microparticulate Dosage Form Which Has Been Designed To Prevent Misuse
App 20080260844 - Soula; Gerard ; et al. | 2008-10-23 |
Prolonged-release multimicroparticulate oral pharmaceutical form
App 20080063725 - Guimberteau; Florence ; et al. | 2008-03-13 |
Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form
App 20080026056 - Guimberteau; Florence ; et al. | 2008-01-31 |
Oral dosage form comprising an antimisuse system
App 20080008659 - Guimberteau; Florence ; et al. | 2008-01-10 |
Multimicroparticulate pharmaceutical forms for oral administration
App 20070264346 - Guimberteau; Florence ; et al. | 2007-11-15 |
Anti-misuse oral microparticle medicinal formulation
App 20070264326 - Guimberteau; Florence ; et al. | 2007-11-15 |
Anti-misuse microparticulate oral pharmaceutical form
App 20070224129 - Guimberteau; Florence ; et al. | 2007-09-27 |
Oral dosage form comprising an antimisuse system
App 20070202049 - Guimberteau; Florence ; et al. | 2007-08-30 |
Oral ribavirin pharmaceutical compositions
App 20070173464 - Guimberteau; Florence ; et al. | 2007-07-26 |
Oral ribavirin pharmaceutical compositions
App 20070166378 - Guimberteau; Florence ; et al. | 2007-07-19 |
Microcapsules with modified release of active principles with low solubility for oral delivery
App 20070160678 - Guimberteau; Florence ; et al. | 2007-07-12 |
Microcapsules with modified release of active principles with low solubility for oral delivery
App 20060275376 - Guimberteau; Florence ; et al. | 2006-12-07 |
Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility
App 20060165809 - Guimberteau; Florence ; et al. | 2006-07-27 |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
App 20060165807 - Castan; Catherine ; et al. | 2006-07-27 |
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
App 20060110463 - Castan; Catherine ; et al. | 2006-05-25 |
Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
App 20050196459 - Castan, Catherine ; et al. | 2005-09-08 |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
App 20050175695 - Castan, Catherine ; et al. | 2005-08-11 |
Novel compositions
App 20040208936 - Chorin, Roland ; et al. | 2004-10-21 |
Method for preparing concentrated and emulsions calibrated in a highly viscous phase, in particular bitumen emulsions
Grant 6,602,917 - Leal Calderon , et al. August 5, 2 | 2003-08-05 |
| 